Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DBH | P09172 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.31 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3783701 | 0.83 | AR (0.37) | DBHTTRP2RX7SLC5A1SLC5A2 | |
| SCHEMBL4632389 | 0.80 | TAAR1 (0.41) | TTRP2RX7SMPD3HCAR2ADORA2A | |
| SCHEMBL4547651 | 0.68 | PTGS2 (0.58) | DBH | |
| SCHEMBL12646239 | 0.67 | SLC5A2 (0.36) | SLC5A1SLC5A2 | |
| SCHEMBL12589092 | 0.67 | SMN1; SMN2 (0.43) | DBH | |
| SCHEMBL4633441 | 0.66 | P2RX7 (0.40) | TTRP2RX7HCAR2 | |
| SCHEMBL3764427 | 0.63 | MAPT (0.50) | DBH | |
| SCHEMBL3775407 | 0.62 | MEN1 (0.43) | — | |
| SCHEMBL3770602 | 0.62 | TAAR1 (0.42) | TTRP2RX7SLC5A1SLC5A2 | |
| SCHEMBL13548271 | 0.62 | HTR2A (0.44) | DBH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912656-A2 | METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES | Boehringer Ingelheim International GmbH (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007014895-A2 | METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-02-08 | — | — | WO | disclosed |